Individualized cardiovascular risk assessment by cardiovascular magnetic resonance

Rocio Hinojar; Rene Botnar; Juan Carlos Kaski; Sanjay Prasad; Eike Nagel; Valentina O Puntmann

doi:10.2217/fca.13.102

Individualized cardiovascular risk assessment by cardiovascular magnetic resonance

Rocio Hinojar, Rene Botnar, Juan Carlos Kaski, Sanjay Prasad, Eike Nagel, Valentina O Puntmann

King's College London

Research output: Contribution to journal › Article › peer-review

19 Citations (Scopus)

Abstract

Cardiovascular magnetic resonance (CMR) is gaining clinical importance in preventive medicine. Evidence on diagnostic accuracy and prognostic value, in addition to the development of faster imaging, increased availability of equipment and imaging expertise have led to a wide-spread use of CMR in a growing number of clinical indications. The first part of this review summarizes the role of CMR biomarkers for risk assessment focusing on the patients groups that benefit from the use of CMR. In the second part, the future directions for CMR are discussed and their role in prevention of cardiovascular disease.

Original language	English
Article number	N/A
Pages (from-to)	273-289
Number of pages	17
Journal	Future Cardiology
Volume	10
Issue number	2
DOIs	https://doi.org/10.2217/fca.13.102
Publication status	Published - Mar 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2217/fca.13.102

Cite this

@article{83f41d48bbf14f998f059a39e347e702,

title = "Individualized cardiovascular risk assessment by cardiovascular magnetic resonance",

abstract = "Cardiovascular magnetic resonance (CMR) is gaining clinical importance in preventive medicine. Evidence on diagnostic accuracy and prognostic value, in addition to the development of faster imaging, increased availability of equipment and imaging expertise have led to a wide-spread use of CMR in a growing number of clinical indications. The first part of this review summarizes the role of CMR biomarkers for risk assessment focusing on the patients groups that benefit from the use of CMR. In the second part, the future directions for CMR are discussed and their role in prevention of cardiovascular disease.",

author = "Rocio Hinojar and Rene Botnar and Kaski, {Juan Carlos} and Sanjay Prasad and Eike Nagel and Puntmann, {Valentina O}",

year = "2014",

month = mar,

doi = "10.2217/fca.13.102",

language = "English",

volume = "10",

pages = "273--289",

journal = "Future Cardiology",

issn = "1479-6678",

publisher = "Future Medicine Ltd.",

number = "2",

}

TY - JOUR

T1 - Individualized cardiovascular risk assessment by cardiovascular magnetic resonance

AU - Hinojar, Rocio

AU - Botnar, Rene

AU - Kaski, Juan Carlos

AU - Prasad, Sanjay

AU - Nagel, Eike

AU - Puntmann, Valentina O

PY - 2014/3

Y1 - 2014/3

N2 - Cardiovascular magnetic resonance (CMR) is gaining clinical importance in preventive medicine. Evidence on diagnostic accuracy and prognostic value, in addition to the development of faster imaging, increased availability of equipment and imaging expertise have led to a wide-spread use of CMR in a growing number of clinical indications. The first part of this review summarizes the role of CMR biomarkers for risk assessment focusing on the patients groups that benefit from the use of CMR. In the second part, the future directions for CMR are discussed and their role in prevention of cardiovascular disease.

AB - Cardiovascular magnetic resonance (CMR) is gaining clinical importance in preventive medicine. Evidence on diagnostic accuracy and prognostic value, in addition to the development of faster imaging, increased availability of equipment and imaging expertise have led to a wide-spread use of CMR in a growing number of clinical indications. The first part of this review summarizes the role of CMR biomarkers for risk assessment focusing on the patients groups that benefit from the use of CMR. In the second part, the future directions for CMR are discussed and their role in prevention of cardiovascular disease.

U2 - 10.2217/fca.13.102

DO - 10.2217/fca.13.102

M3 - Article

C2 - 24762254

SN - 1479-6678

VL - 10

SP - 273

EP - 289

JO - Future Cardiology

JF - Future Cardiology

IS - 2

M1 - N/A

ER -

Individualized cardiovascular risk assessment by cardiovascular magnetic resonance

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this